On Friday, Shares of Lipocine Inc (NASDAQ: LPCN), added 29.74% and closed at $5.41 in the last trading session. The last trading range of the stock ranges between $5.11 and $5.90. The company’s Market capitalization is $128.15 million with the total Outstanding Shares of 18.26 million. During the 52-week trading session the minimum price at which share price traded, registered at $2.51 and reached to max level of $14.80.Lipocine Inc. (LPCN), a specialty pharmaceutical company, recently declared that U.S. District Court in Delaware granted our motion to dismiss a lawsuit filed by Clarus Therapeutics, Inc. (“Clarus”). Clarus claimed that LPCN 1021 infringed Clarus’ patent (U.S. Patent No. 8,828,428). LPCN 1021 is Lipocine’s oral testosterone product candidate for testosterone replacement therapy (“TRT”) in adult males for conditions associated with a deficiency or absence of endogenous testosterone, also known as hypogonadism.
“We are happy that the court has dismissed this lawsuit. Going forward, we will continue to aggressively defend our intellectual property,” said Dr. Mahesh Patel, President and CEO of Lipocine Inc. “We believe that LPCN 1021 has the potential to improve the ease of use contrast to the available formulations, counting topical gels and injections, and to overcome inadvertent testosterone transference risk to children and partners that exist with topical gels.”
Morgan Stanley(NYSE:MS), dropped -0.25% and closed at $32.31 in the last trading session. The last trading range of the stock ranges between $31.95 and $32.52. The company’s Market capitalization is $61.62 Billion with the total Outstanding Shares of 1.91 Billion. During the 52-week trading session the minimum price at which share price traded, registered at $21.16 and reached to max level of $35.74. Investment funds managed by Morgan Stanley Global Private Equity (MSPE) declared recently that they have accomplished an investment in 24 Seven, Inc., one of North America’s leading creative and digital human capital administration firms. MSPE is partnering with the founder, Celeste Gudas, and the current administration team who will remain in place and retain a noteworthyequity stake.
24 Seven is one of North America’s preeminent human capital administration firms specializing in the placement of freelance and full-time creative, marketing and digital talent. Through a network of nine U.S. offices and two international offices, the company delivers advertising, creative, marketing and interactive / digital professionals for freelance and permanent placements. Clients include a combination of corporate marketing departments and marketing agencies. Morgan Stanley Global Private Equity believes 24 Seven attracts and places high quality talent through a consultative relationship driven approach, and has demonstrated consistently strong growth and increasing profitability.
On the other hand share Kroger Co (NYSE:KR), lost -1.26% and closed at $29.00 in the last trading session. The last trading range of the stock ranges between $29.00 and $29.59. The company’s Market capitalization is $27.04 Billion with the total Outstanding Shares of 944.17 million. During the 52-week trading session the minimum price at which share price traded, registered at $28.71 and reached to max level of $42.75. The Kroger Co. (KR) recently launched its annual #SharingCourage campaign, lighting its headquarters building pink and encouraging customers to join in the fight against breast cancer by taking action online and in their communities.
“No one should face breast cancer alone, so Kroger is proud to be a partner in the fight and to share the stories of our courageous associates who are breast cancer survivors,” said Jessica Adelman, Kroger’s group vice president of corporate affairs.